KR880012235A - 정상 포유동물의 헤마토크릿을 증가시키는 방법 - Google Patents

정상 포유동물의 헤마토크릿을 증가시키는 방법 Download PDF

Info

Publication number
KR880012235A
KR880012235A KR1019880003863A KR880003863A KR880012235A KR 880012235 A KR880012235 A KR 880012235A KR 1019880003863 A KR1019880003863 A KR 1019880003863A KR 880003863 A KR880003863 A KR 880003863A KR 880012235 A KR880012235 A KR 880012235A
Authority
KR
South Korea
Prior art keywords
iron
epo
administered
mammal
effective amount
Prior art date
Application number
KR1019880003863A
Other languages
English (en)
Korean (ko)
Inventor
에프. 에이.반스 죤
아이.아벨 로버트
Original Assignee
벤자민 에프.람버트
오르토 파마슈티칼 코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21889805&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR880012235(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 벤자민 에프.람버트, 오르토 파마슈티칼 코포레이션 filed Critical 벤자민 에프.람버트
Publication of KR880012235A publication Critical patent/KR880012235A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Electrotherapy Devices (AREA)
  • Peptides Or Proteins (AREA)
KR1019880003863A 1987-04-10 1988-04-07 정상 포유동물의 헤마토크릿을 증가시키는 방법 KR880012235A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3664687A 1987-04-10 1987-04-10
US036646 1987-04-10

Publications (1)

Publication Number Publication Date
KR880012235A true KR880012235A (ko) 1988-11-26

Family

ID=21889805

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880003863A KR880012235A (ko) 1987-04-10 1988-04-07 정상 포유동물의 헤마토크릿을 증가시키는 방법

Country Status (13)

Country Link
US (1) US5541158A (ja)
EP (1) EP0286439B1 (ja)
JP (1) JP2858752B2 (ja)
KR (1) KR880012235A (ja)
AT (1) ATE70978T1 (ja)
AU (1) AU613905B2 (ja)
DE (1) DE3867285D1 (ja)
DK (1) DK167903B1 (ja)
ES (1) ES2035279T3 (ja)
GR (1) GR3004071T3 (ja)
IE (1) IE61008B1 (ja)
NO (1) NO881507D0 (ja)
PT (1) PT87197B (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
DE19535571A1 (de) * 1995-09-14 1997-03-20 Boehringer Mannheim Gmbh Pharmazeutische Kombinationspräparate und deren Verwendung zur Behandlung von Hämodialysepatienten
WO1997022336A1 (en) * 1995-12-21 1997-06-26 Smithkline Beecham Corporation Direct compression carbonyl iron tablet
US5952226A (en) * 1996-11-05 1999-09-14 Modex Therapeutiques Hypoxia responsive EPO producing cells
DE59707988D1 (de) * 1997-03-18 2002-09-19 Roche Diagnostics Gmbh Pharmazeutische kombinationspräparate enthaltend erythropoietin und eisenpräparate
US7033774B2 (en) * 1997-04-21 2006-04-25 Glycozyme, Inc. Determination of recombinant glycosylated proteins and peptides in biological fluids
EP0885613A1 (de) * 1997-06-21 1998-12-23 Roche Diagnostics GmbH Verwendung von modifizierten Hämoglobinen zur Behandlung von Anämien und Kombinationspräparate umfassend Erythropoietin und modifiziertes Hämoglobin
JP2002509077A (ja) 1998-02-09 2002-03-26 ユニヴァースティ オブ サザーン カリフォルニア 赤血球形成促進方法
US7304150B1 (en) * 1998-10-23 2007-12-04 Amgen Inc. Methods and compositions for the prevention and treatment of anemia
MXPA01011429A (es) * 1999-05-11 2003-09-10 Ortho Mcneil Pharm Inc Modelado farmacocinetico y farmacodinamico de administracion de eritropoyetina.
US7459435B2 (en) 2002-08-29 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
US7459436B2 (en) 2002-11-22 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
PT1973549T (pt) 2006-01-06 2016-10-25 Luitpold Pharm Inc Métodos e composições para administração de ferro

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57149228A (en) * 1981-03-11 1982-09-14 Ajinomoto Co Inc Novel erythropoietin and its preparation
US4732889A (en) * 1985-02-06 1988-03-22 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition for the treatment of the anemia of rheumatoid arthritis
JPS6231A (ja) * 1985-02-06 1987-01-06 Chugai Pharmaceut Co Ltd 腎性貧血治療剤
US4745099A (en) * 1985-02-06 1988-05-17 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition for the treatment of the anemia of malignant tumors
GB2177914B (en) * 1985-06-04 1989-10-25 Chugai Pharmaceutical Co Ltd A pharmaceutical composition containing human erythropoietin and a surface active agent for nasal administration for the treatment of anemia
US5013718A (en) * 1986-11-21 1991-05-07 Amgen, Inc. Method for treating iron overload using EPO
JPS63227527A (ja) * 1987-03-05 1988-09-21 キリン―アムジエン（デラウエア）インコーポレーテツド 貧血予防薬

Also Published As

Publication number Publication date
EP0286439B1 (en) 1992-01-02
NO881507D0 (no) 1988-04-07
AU613905B2 (en) 1991-08-15
JPS63277630A (ja) 1988-11-15
EP0286439A1 (en) 1988-10-12
GR3004071T3 (ja) 1993-03-31
ATE70978T1 (de) 1992-01-15
DE3867285D1 (de) 1992-02-13
AU1444588A (en) 1988-10-13
DK194288D0 (da) 1988-04-08
PT87197A (pt) 1988-05-01
US5541158A (en) 1996-07-30
IE881064L (en) 1988-10-09
JP2858752B2 (ja) 1999-02-17
DK167903B1 (da) 1994-01-03
ES2035279T3 (es) 1995-04-01
DK194288A (da) 1988-10-11
PT87197B (pt) 1992-07-31
IE61008B1 (en) 1994-09-07

Similar Documents

Publication Publication Date Title
KR880012235A (ko) 정상 포유동물의 헤마토크릿을 증가시키는 방법
KR900013961A (ko) 기억력 및 학습력 증강 또는 인식 또는 정신장해 치료용 d-시클로세린 및 d-알라닌 함유 조성물
HK1023943A1 (en) Medicament for the treatment of diabetes mellitus as well as its subsequent disorders
RU2005131832A (ru) Композиция для введения железа при лечении синдрома беспокойных ног
GR860900B (en) Amino-propanol derivatives method for their preparation their use and medicaments containing them
Coggeshall The selective action of sulfanilamide on the parasites of experimental malaria in monkeys in vivo and in vitro
EP0303236A3 (en) Lignosulfonate based pharmacologic agent with anti-thrombotic activity
DE602004014760D1 (de) Transfusionszubereitung zur peripheren intravenösen verabreichung und verfahren zur stabilisierung von vitamin b1
KR880002527A (ko) 신경변질 치료용 안 조성물
KR890701526A (ko) 각화증 치료제
EP1103269A4 (en) PREPARATIONS FOR THE ADMINISTRATION OF A HEPATOCYTE GROWTH FACTOR
DORSEY et al. Studies on the mode of action of glucocorticoids in rats: a comparison of the effects of cortisol and glucose on the formation of liver glycogen
GR3035287T3 (en) Insulin and amylin containing composition for the treatment of insulin deficient mammals.
Granolleras et al. Two years experience of daily self-administered subcutaneous erythropoietin
KR890001552A (ko) 심부정맥 치료방법
DE69002743T2 (de) Verfahren zur Verbesserung der Ventilation während des Schlafes und Behandlung von Ventilationsabnormalitäten, die mit dem Schlaf verbunden sind.
KR890014113A (ko) 로도카인을 함유하는 안과용 마취제 조성물 및 마취방법
STOELTING Comparison of gallamine and atropine as pretreatment before anesthetic induction and succinylcholine administration
MEYER et al. Intravenous Treatment of Pernicious Anemia with Vitamin B12
Al-Jibouri et al. The effects of dipyridamole and methylprednisolone or their combination on some metabolic and hematological disturbances during late sepsis in rats
Buemi et al. Different answer to recombinant human erythropoietin in anephric and non-anephric haemodialyzed patients
SU1560216A1 (ru) Способ поддержани сниженного артериального давлени при операци х на сосудах головного мозга
Smith et al. Effects of L-tyrosine on brain monoamines in rats given intravenous amphetamine.
KR930702983A (ko) 난소암의 치료
RU93019884A (ru) Способ лечения острых гепатитов

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid